Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.
The extent of human T-cell leukemia/lymphoma virus type II (HTLV-II) infection and its rate of spread have been difficult to determine owing to the serological cross-reactivity between HTLV-I and HTLV-II. The present study overcame this problem by directly detecting type-specific proviral sequences by means of the polymerase chain reaction (PCR) and liquid hybridization. Screening was performed on a cohort of primarily white intravenous drug abusers (IVDAs), and individuals of other behaviorally defined risk groups from the New York City area. Eleven percent (19 of 169) of the individuals in these high-risk groups were determined by PCR to have HTLV-II proviral infections. One of these patients displayed an exfoliative erythrodermatitis. Thirteen of the 19 subjects were positive in an HTLV-II enzyme-linked immunosorbent assay (ELISA). The remaining six individuals, although negative in the HTLV-II ELISA, were confirmed as HTLV-II positive by analyzing their DNA with a second HTLV-II-specific primer detector system. Four additional individuals were reactive in the HTLV-II ELISA but were PCR-negative for HTLV-II. PCR analysis for HTLV-I revealed that all four were positive for that virus. Thirty-seven percent (seven of 19) of the HTLV-II PCR-positive subjects were also PCR-positive for HTLV-I, and 84% (16 of 19) of the HTLV-II positive individuals were infected with human immunodeficiency virus (HIV-1). Six individuals were triply infected with HTLV-I, HTLV-II, and HIV-1.
Ehrlich
G D
GD
Department of Medicine, SUNY-HSC, Syracuse, NY.
Glaser
J B
JB
LaVigne
K
K
Quan
D
D
Mildvan
D
D
Sninsky
J J
JJ
Kwok
S
S
Papsidero
L
L
Poiesz
B J
BJ
D004797:Enzyme-Linked Immunosorbent Assay; D005006:Ethnicity; D005260:Female; D005814:Genes, Viral; D015482:HTLV-II Antibodies / Q000032:analysis; D015491:HTLV-II Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D015367:Human T-lymphotropic virus 2 / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D009519:New York City; D016133:Polymerase Chain Reaction; D015995:Prevalence; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000150:complications; D065227:Transfusion Reaction
D015482:HTLV-II Antibodies